$6.52 Billion is the total value of Eventide Asset Management's 158 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 43.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $212,304,000 | +55.4% | 1,002,285 | +0.8% | 3.26% | +21.8% |
| FIVN | Buy | FIVE9 INC | $203,920,000 | +35.7% | 1,169,268 | +0.9% | 3.13% | +6.3% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $183,766,000 | – | 3,513,081 | +100.0% | 2.82% | – |
| TWLO | Buy | TWILIO INCcl a | $132,384,000 | +38.1% | 391,090 | +0.8% | 2.03% | +8.2% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $132,000,000 | +31.9% | 306,200 | +20.9% | 2.02% | +3.4% |
| IDXX | Buy | IDEXX LABS INC | $119,969,000 | +51.8% | 240,000 | +19.4% | 1.84% | +18.9% |
| DT | Buy | DYNATRACE INC | $117,435,000 | +8.2% | 2,714,008 | +2.6% | 1.80% | -15.2% |
| MTD | Buy | METTLER TOLEDO INTERNATIONAL | $117,387,000 | +33.6% | 103,000 | +13.2% | 1.80% | +4.7% |
| FVRR | Buy | FIVERR INTL LTD | $102,812,000 | +43.1% | 526,971 | +1.9% | 1.58% | +12.2% |
| LRCX | Buy | LAM RESEARCH CORP | $96,381,000 | +44.0% | 204,081 | +1.1% | 1.48% | +12.7% |
| HUBS | Buy | HUBSPOT INC | $93,951,000 | +36.4% | 236,987 | +0.6% | 1.44% | +6.9% |
| POOL | Buy | POOL CORP | $93,795,000 | +12.2% | 251,800 | +0.8% | 1.44% | -12.1% |
| ZI | Buy | ZOOMINFO TECHNOLOGIES INC | $91,582,000 | +104.1% | 1,898,851 | +81.9% | 1.40% | +59.7% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $89,525,000 | +17.1% | 1,335,200 | +4.7% | 1.37% | -8.3% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $88,127,000 | +23.2% | 607,100 | +2.9% | 1.35% | -3.5% |
| VRSK | Buy | VERISK ANALYTICS INC | $87,042,000 | +40.9% | 419,300 | +25.8% | 1.34% | +10.4% |
| LOW | Buy | LOWES COS INC | $84,476,000 | -1.0% | 526,300 | +2.3% | 1.30% | -22.5% |
| RNG | Buy | RINGCENTRAL INCcl a | $81,819,000 | +87.0% | 215,898 | +35.5% | 1.26% | +46.4% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $71,039,000 | +112.3% | 583,000 | +52.2% | 1.09% | +66.3% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $71,046,000 | +10.1% | 364,000 | +2.1% | 1.09% | -13.8% |
| Buy | TRILLIUM THERAPEUTICS INC | $70,335,000 | +54.8% | 4,781,448 | +49.6% | 1.08% | +21.4% | |
| CTAS | Buy | CINTAS CORP | $63,269,000 | +42.9% | 179,000 | +34.6% | 0.97% | +11.9% |
| MGA | Buy | MAGNA INTL INC | $56,874,000 | +56.7% | 803,300 | +1.3% | 0.87% | +22.8% |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $53,333,000 | +14.4% | 1,236,000 | +39.3% | 0.82% | -10.4% |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $52,786,000 | +51.0% | 832,200 | +0.6% | 0.81% | +18.3% |
| PANW | Buy | PALO ALTO NETWORKS INC | $52,784,000 | +48.4% | 148,523 | +2.2% | 0.81% | +16.2% |
| DHI | Buy | D R HORTON INC | $52,365,000 | -3.8% | 759,800 | +5.6% | 0.80% | -24.6% |
| VITL | New | VITAL FARMS INC | $51,967,000 | – | 2,053,232 | +100.0% | 0.80% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $51,474,000 | +157.9% | 2,370,975 | +19.4% | 0.79% | +101.8% |
| ANNX | Buy | ANNEXON INC | $49,177,000 | -6.1% | 2,004,616 | +13.1% | 0.75% | -26.5% |
| YETI | New | YETI HLDGS INC | $47,244,000 | – | 690,000 | +100.0% | 0.72% | – |
| SPT | Buy | SPROUT SOCIAL INC | $46,088,000 | +22.2% | 1,014,920 | +3.6% | 0.71% | -4.3% |
| DDOG | Buy | DATADOG INC | $46,011,000 | +34.3% | 467,403 | +39.4% | 0.71% | +5.2% |
| ALLK | Buy | ALLAKOS INC | $44,380,000 | +240.5% | 317,000 | +98.1% | 0.68% | +167.1% |
| FRLN | Buy | FREELINE THERAPEUTICS HLDGSsponsored ads | $44,266,000 | +24.3% | 2,485,656 | +6.1% | 0.68% | -2.6% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $44,159,000 | -2.2% | 277,400 | +2.2% | 0.68% | -23.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $43,279,000 | +319.4% | 1,946,000 | +178.3% | 0.66% | +228.7% |
| CWEN | Buy | CLEARWAY ENERGY INCcl c | $39,826,000 | +884.1% | 1,247,300 | +731.0% | 0.61% | +673.4% |
| EDIT | New | EDITAS MEDICINE INCput | $37,954,000 | – | 583,900 | +100.0% | 0.58% | – |
| KURA | Buy | KURA ONCOLOGY INC | $34,620,000 | +182.5% | 1,060,000 | +165.0% | 0.53% | +121.2% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $34,524,000 | +98.7% | 1,050,000 | +111.0% | 0.53% | +55.6% |
| ADCT | Buy | ADC THERAPEUTICS SA | $34,411,000 | +79.7% | 1,075,000 | +85.2% | 0.53% | +40.8% |
| GNRC | New | GENERAC HLDGS INC | $32,520,000 | – | 143,000 | +100.0% | 0.50% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $32,186,000 | +328.7% | 1,837,108 | +262.9% | 0.49% | +236.1% |
| MDB | Buy | MONGODB INCcl a | $31,947,000 | +57.2% | 88,980 | +1.3% | 0.49% | +23.1% |
| NTLA | New | INTELLIA THERAPEUTICS INCput | $30,327,000 | – | 551,400 | +100.0% | 0.46% | – |
| ROL | Buy | ROLLINS INC | $28,423,000 | +8.1% | 727,500 | +50.0% | 0.44% | -15.2% |
| SWKS | Buy | SKYWORKS SOLUTIONS INC | $27,602,000 | +20.1% | 180,547 | +14.3% | 0.42% | -6.0% |
| BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $27,235,000 | +63.0% | 467,400 | +63.9% | 0.42% | +27.8% |
| MPWR | Buy | MONOLITHIC PWR SYS INC | $26,683,000 | +34.5% | 72,859 | +2.7% | 0.41% | +5.4% |
| KROS | New | KEROS THERAPEUTICS INC | $24,407,000 | – | 346,000 | +100.0% | 0.37% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $23,963,000 | +47.2% | 387,000 | +30.3% | 0.37% | +15.0% |
| SHC | New | SOTERA HEALTH CO | $23,873,000 | – | 870,000 | +100.0% | 0.37% | – |
| XNCR | Buy | XENCOR INC | $22,077,000 | +89.7% | 506,000 | +68.7% | 0.34% | +48.7% |
| LGVW | New | LONGVIEW ACQUISITION CORP | $22,125,000 | – | 1,118,000 | +100.0% | 0.34% | – |
| ETNB | Buy | 89BIO INC | $21,178,000 | +22.3% | 869,000 | +28.7% | 0.32% | -4.1% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $19,932,000 | +20.8% | 600,000 | +33.3% | 0.31% | -5.3% |
| MASS | New | 908 DEVICES INC | $18,980,000 | – | 333,283 | +100.0% | 0.29% | – |
| SGEN | New | SEAGEN INC | $17,952,000 | – | 102,500 | +100.0% | 0.28% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $15,824,000 | – | 341,473 | +100.0% | 0.24% | – |
| ORIC | New | ORIC PHARMACEUTICALS INC | $14,556,000 | – | 430,000 | +100.0% | 0.22% | – |
| MKC | Buy | MCCORMICK & CO INC | $12,317,000 | +1.4% | 128,840 | +105.8% | 0.19% | -20.6% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $12,072,000 | – | 300,000 | +100.0% | 0.18% | – |
| GLPG | Buy | GALAPAGOS NVspon adr | $11,086,000 | +53.2% | 112,000 | +119.6% | 0.17% | +19.7% |
| A | Buy | AGILENT TECHNOLOGIES INC | $10,960,000 | +47.9% | 92,500 | +26.0% | 0.17% | +15.9% |
| New | APTOSE BIOSCIENCES INC | $10,070,000 | – | 2,299,000 | +100.0% | 0.15% | – | |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $9,448,000 | +121.0% | 64,300 | +64.0% | 0.14% | +72.6% |
| ITT | Buy | ITT INC | $9,073,000 | +51.7% | 117,800 | +16.3% | 0.14% | +18.8% |
| PLD | Buy | PROLOGIS INC. | $9,079,000 | +18.0% | 91,100 | +19.1% | 0.14% | -7.9% |
| FHN | Buy | FIRST HORIZON CORPORATION | $8,852,000 | +331.0% | 693,700 | +218.5% | 0.14% | +240.0% |
| ENTG | Buy | ENTEGRIS INC | $7,460,000 | +69.9% | 77,629 | +31.4% | 0.11% | +32.6% |
| KNTE | New | KINNATE BIOPHARMA INC | $6,962,000 | – | 175,000 | +100.0% | 0.11% | – |
| KLAC | Buy | KLA CORP | $6,602,000 | +52.3% | 25,498 | +14.0% | 0.10% | +18.8% |
| JKHY | Buy | HENRY JACK & ASSOC INC | $6,501,000 | +50.9% | 40,132 | +51.4% | 0.10% | +19.0% |
| New | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $6,124,000 | – | 4,334,000 | +100.0% | 0.09% | – | |
| STE | Buy | STERIS PLC | $5,999,000 | +16.6% | 31,650 | +8.4% | 0.09% | -8.9% |
| PNR | New | PENTAIR PLC | $5,314,000 | – | 100,100 | +100.0% | 0.08% | – |
| SBAC | New | SBA COMMUNICATIONS CORP NEWcl a | $4,928,000 | – | 17,466 | +100.0% | 0.08% | – |
| SNPS | Buy | SYNOPSYS INC | $4,487,000 | +127.0% | 17,309 | +87.4% | 0.07% | +76.9% |
| SYY | Buy | SYSCO CORP | $4,084,000 | +77.9% | 55,000 | +49.1% | 0.06% | +40.0% |
| ZTS | Buy | ZOETIS INCcl a | $3,674,000 | +26.2% | 22,200 | +26.1% | 0.06% | -1.8% |
| Buy | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $3,570,000 | +20.5% | 2,569,000 | +20.1% | 0.06% | -5.2% | |
| IEX | Buy | IDEX CORP | $3,491,000 | +73.9% | 17,524 | +59.3% | 0.05% | +38.5% |
| SBNY | New | SIGNATURE BK NEW YORK N Y | $3,504,000 | – | 25,900 | +100.0% | 0.05% | – |
| MSCI | Buy | MSCI INC | $3,193,000 | +98.8% | 7,150 | +58.9% | 0.05% | +58.1% |
| NXPI | New | NXP SEMICONDUCTORS N V | $2,894,000 | – | 18,200 | +100.0% | 0.04% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $2,813,000 | +90.7% | 25,800 | +41.8% | 0.04% | +48.3% |
| GRMN | New | GARMIN LTD | $2,501,000 | – | 20,900 | +100.0% | 0.04% | – |
| NDAQ | New | NASDAQ INC | $2,496,000 | – | 18,800 | +100.0% | 0.04% | – |
| FOUR | New | SHIFT4 PMTS INCcl a | $2,402,000 | – | 31,860 | +100.0% | 0.04% | – |
| MAX | New | MEDIAALPHA INCcl a added | $2,407,000 | – | 61,611 | +100.0% | 0.04% | – |
| VFC | New | V F CORP | $2,016,000 | – | 23,600 | +100.0% | 0.03% | – |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $1,882,000 | +458.5% | 20,524 | +399.6% | 0.03% | +314.3% |
| FATE | New | FATE THERAPEUTICS INCput | $1,796,000 | – | 18,900 | +100.0% | 0.03% | – |
| LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $1,601,000 | +128.7% | 34,944 | +44.6% | 0.02% | +78.6% |
| OM | Buy | OUTSET MED INC | $1,491,000 | +118.6% | 26,237 | +92.4% | 0.02% | +76.9% |
| SLAB | Buy | SILICON LABORATORIES INC | $1,171,000 | +174.2% | 9,198 | +110.6% | 0.02% | +125.0% |
| DOCU | Buy | DOCUSIGN INC | $1,071,000 | +70.0% | 4,819 | +64.8% | 0.02% | +33.3% |
| LMND | New | LEMONADE INCput | $935,000 | – | 17,000 | +100.0% | 0.01% | – |
| NEWR | New | NEW RELIC INCput | $660,000 | – | 12,000 | +100.0% | 0.01% | – |
| AMWL | New | AMERICAN WELL CORPput | $525,000 | – | 21,000 | +100.0% | 0.01% | – |
| APPN | New | APPIAN CORPput | $375,000 | – | 3,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.